SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 4.31 |
| Enterprise Value ($M) | -5.41 |
| Book Value ($M) | 7.30 |
| Book Value / Share | 1.34 |
| Price / Book | 0.59 |
| NCAV ($M) | 7.30 |
| NCAV / Share | 1.34 |
| Price / NCAV | 0.59 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.57 |
| Return on Assets (ROA) | -2.21 |
| Return on Equity (ROE) | -3.01 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.70 |
| Current Ratio | 3.70 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 10.01 |
| Assets | 10.01 |
| Liabilities | 2.70 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -12.51 |
| Net Income | -12.29 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -11.16 |
| Cash from Investing | 0.00 |
| Cash from Financing | 6.89 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 9.99 | 285.31 | |
| 13G/A | Intracoastal Capital, Llc | 0.40 | -91.11 | |
| 13D/A | Proehl Gerald T | 13.30 | 245.06 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 17,502 | 48,874 | 35.81 | |
| 30,025 | 62,887 | 47.74 | |
| 14,224 | 63,515 | 22.39 | |
| 30,359 | 123,438 | 24.59 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| DERM – Journey Medical Corporation | DMAC – DiaMedica Therapeutics Inc. |
| DNTH – Dianthus Therapeutics, Inc. | DRRX – DURECT Corporation |
| DRUG – Bright Minds Biosciences Inc. |
Financial data and stock pages provided by
Fintel.io